Clinical Trial Update: A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects [Phase 3]

View source ↗

Summary

This update notes the termination of a Phase 3 study evaluating long-term safety, tolerability, and efficacy of drisapersen in US and Canadian subjects with mus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Drisapersen (drisapersen)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Muscular Dystrophies | Phase 3 | Status: TERMINATED